Human Clinical Supports Glisodin Melon Extract for Sports
Glisodin has shown to exhibit positive effects on selected inflammatory markers.
Glisodin, a plant superoxide dismutase (SOD) extract derived from melon (Cucumis melo LC), has shown to exhibit positive effects on selected inflammatory markers in a new human clinical study published in The International Journal of Sports Nutrition and Exercise Metabolism. The announcement was made by P.L. Thomas (Morristown, NJ), which markets the ingredient. Glisodin is an ingredient of Isocell S.A. (Paris).
The double-blind study involved 19 members of the Polish National Rowing Team. Subjects were randomly assigned to take 500 mg of Glisodin extract once daily for six weeks, or placebo. At the beginning and end of the study, subjects performed a 2000-meter rowing ergometer test. Blood samples were taken before each test, one minute after test completion, and again after a 24-hour rest period.
Researchers found that SOD activity was significantly higher in the supplemented group during all tests, and post-exercise C-reactive protein was significantly lower. They concluded that the supplementation promoted antioxidant status and protected against increased inflammation.
“The present trial confirms the findings of previous studies demonstrating the benefits of Glisodin for lessening inflammation resulting from strenuous exercise,” stated Francois Vix, president of Isocell. He adds that C-reactive protein is a measure of muscle inflammation.
Glisodin has also been studied for its immune-health benefits.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
